10989365 · Active · incorporated 8 years, 10 months ago · Abingdon
Biotech Biotech & Life Sciences Drug Discovery Series B+
A clinical-stage biotechnology company developing novel antigen modulation technology to guide the immune system for cancer treatment.
https://www.greywolftherapeutics.com/
See the complete cap table with every shareholder, founder tags, dilution across 41 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.